Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development.

KITTLESEN D J; THOMPSON L W; GULDEN P H; SKIPPER J C A; COLELLA T A; SHABANOWITZ J A; HUNT D F; ENGELHARD V H; SLINGLUFF C L JR

Art

J-GLOBAL ID：200902193056697211 Reference number：98A0377517

Human Melanoma Patients Recognize an HLA-A1-Restricted CTL Epitope from Tyrosinase Containing Two Cysteine Residues: Implications for Tumor Vaccine Development.

ヒトメラノーマ患者は二つのシステイン残基を含むチロシナーゼ由来HLA-A1拘束性CTLエピトープを認識する腫ようワクチン開発への示唆

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=98A0377517&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=98A0377517&from=J-GLOBAL&jstjournalNo=H0775A") }}

Author (9)： , , , , , , , ,
Material：
Volume： 160 Issue： 5 Page： 2099-2106 Publication year： Mar. 01, 1998
JST Material Number： H0775A ISSN： 0022-1767 CODEN： JOIMA3 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=98A0377517&from=J-GLOBAL&jstjournalNo=H0775A") }}

Tumor immunity

, , , , , , , , ,

Return to Previous Page